Strategies for bioanalytical method development & validation
20 Jan 2025

Erik Jerks, Director, Bioanalytical Sciences and Service at Eurofins, discusses strategies for bioanalytical method development and validation, highlighting Eurofin's expertise in bioanalytical assays for biologics. The video covers three case studies that address challenges in assay development for bispecific multitarget antibodies and adeno associated virus (AAV)-based drugs. Here, Jerks underscores the importance of evolving technologies and robust automated instrumentation in tackling bioanalytical challenges from multiple angles, ultimately delivering high-quality solutions tailored to client needs. Download the free handout for further detail or contact: ClinicalTrials@VBP.EurofinsUS.com for further information.
About the company
Eurofins Clinical Trial Solutions
Complex innovative clinical trial designs require an integrated synergetic approach to assess novel drug compounds for safety and effectiveness which often span esoteric, regulated and safety outcomes in all phases of the drug development life cycle. The companies of Eurofins Bioanalytical Services, the Eurofins Central Laboratory global network, Eurofins Viracor BioPharma Services, and Eurofins Clinical Trial Supplies are building a stronger connection to provide a seamless solutions-based approach to our client needs. Eurofins Clinical Trial Solutions provides seamless, end-to-end solutions to help clients progress through the drug development cycle through a single, experienced provider. Our integrated solutions deliver the most comprehensive range of state-of-the-art analytical technologies with an expansive geographic reach in order to support our clients’ specialized testing needs and stringent quality and safety requirements around the world.

